# Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples

> **NCT06651346** · — · NOT_YET_RECRUITING · sponsor: **University of Virginia** · enrollment: 100 (estimated)

## Conditions studied

- Cholangiocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06651346
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-10-31
- **Final completion:** 2027-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06651346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06651346, "Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06651346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
